Innovations for health solutions
Bioncotech Therapeutics is a biopharmaceutical company focused on the development of a new agent in immuno-oncology.
A highly qualified and experienced team.
BO-112, an innovative compound that involves a potent anti-tumoral mechanism with an innovative and sustained mode of action.
Bioncotech starts clinical development for its dsRNA based drug candidate
New drugs to fight aggressive cancer
New strategies against cancer: Bioncotech’s case
Article published by "Fundación Botín" Read